Logo image of CVE-PR-E.CA

CENOVUS ENERGY INC - CVECN 4.591 PERP (CVE-PR-E.CA) Stock Fundamental Analysis

TSX:CVE-PR-E - Toronto Stock Exchange - CA15135U7033 - Currency: CAD

25.23  0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CVE-PR-E. CVE-PR-E was compared to 219 industry peers in the Oil, Gas & Consumable Fuels industry. CVE-PR-E has an average financial health and profitability rating. CVE-PR-E has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CVE-PR-E had positive earnings in the past year.
In the past year CVE-PR-E had a positive cash flow from operations.
CVE-PR-E had positive earnings in 4 of the past 5 years.
CVE-PR-E had a positive operating cash flow in each of the past 5 years.
CVE-PR-E.CA Yearly Net Income VS EBIT VS OCF VS FCFCVE-PR-E.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

With an excellent Return On Assets value of 5.49%, CVE-PR-E belongs to the best of the industry, outperforming 81.90% of the companies in the same industry.
CVE-PR-E has a Return On Equity of 10.44%. This is amongst the best in the industry. CVE-PR-E outperforms 80.09% of its industry peers.
With an excellent Return On Invested Capital value of 8.18%, CVE-PR-E belongs to the best of the industry, outperforming 83.71% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CVE-PR-E is above the industry average of 7.60%.
Industry RankSector Rank
ROA 5.49%
ROE 10.44%
ROIC 8.18%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
CVE-PR-E.CA Yearly ROA, ROE, ROICCVE-PR-E.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

CVE-PR-E has a Profit Margin (5.72%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CVE-PR-E has declined.
CVE-PR-E has a Operating Margin (9.37%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CVE-PR-E has grown nicely.
CVE-PR-E has a Gross Margin (32.49%) which is comparable to the rest of the industry.
CVE-PR-E's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.37%
PM (TTM) 5.72%
GM 32.49%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
CVE-PR-E.CA Yearly Profit, Operating, Gross MarginsCVE-PR-E.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

CVE-PR-E has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CVE-PR-E has been reduced compared to 1 year ago.
The number of shares outstanding for CVE-PR-E has been increased compared to 5 years ago.
The debt/assets ratio for CVE-PR-E is higher compared to a year ago.
CVE-PR-E.CA Yearly Shares OutstandingCVE-PR-E.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CVE-PR-E.CA Yearly Total Debt VS Total AssetsCVE-PR-E.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

CVE-PR-E has an Altman-Z score of 2.61. This is not the best score and indicates that CVE-PR-E is in the grey zone with still only limited risk for bankruptcy at the moment.
CVE-PR-E has a Altman-Z score of 2.61. This is amongst the best in the industry. CVE-PR-E outperforms 80.09% of its industry peers.
The Debt to FCF ratio of CVE-PR-E is 2.52, which is a good value as it means it would take CVE-PR-E, 2.52 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.52, CVE-PR-E belongs to the top of the industry, outperforming 83.26% of the companies in the same industry.
CVE-PR-E has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
CVE-PR-E has a Debt to Equity ratio (0.34) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.52
Altman-Z 2.61
ROIC/WACC1.14
WACC7.2%
CVE-PR-E.CA Yearly LT Debt VS Equity VS FCFCVE-PR-E.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

CVE-PR-E has a Current Ratio of 1.42. This is a normal value and indicates that CVE-PR-E is financially healthy and should not expect problems in meeting its short term obligations.
CVE-PR-E has a Current ratio of 1.42. This is in the better half of the industry: CVE-PR-E outperforms 71.49% of its industry peers.
CVE-PR-E has a Quick Ratio of 1.42. This is a bad value and indicates that CVE-PR-E is not financially healthy enough and could expect problems in meeting its short term obligations.
CVE-PR-E has a Quick ratio (0.81) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.81
CVE-PR-E.CA Yearly Current Assets VS Current LiabilitesCVE-PR-E.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

5

3. Growth

3.1 Past

CVE-PR-E shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.59%.
CVE-PR-E shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.99% yearly.
CVE-PR-E shows a small growth in Revenue. In the last year, the Revenue has grown by 3.97%.
CVE-PR-E shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.88% yearly.
EPS 1Y (TTM)-22.59%
EPS 3Y87.24%
EPS 5Y33.99%
EPS Q2Q%-81.79%
Revenue 1Y (TTM)3.97%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-9.19%

3.2 Future

CVE-PR-E is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.34% yearly.
The Revenue is expected to decrease by -3.42% on average over the next years.
EPS Next Y31.65%
EPS Next 2Y26.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.97%
Revenue Next 2Y-4.95%
Revenue Next 3Y-3.42%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CVE-PR-E.CA Yearly Revenue VS EstimatesCVE-PR-E.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
CVE-PR-E.CA Yearly EPS VS EstimatesCVE-PR-E.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 -1 2 -2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.38, the valuation of CVE-PR-E can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of CVE-PR-E indicates a somewhat cheap valuation: CVE-PR-E is cheaper than 61.54% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. CVE-PR-E is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 11.68, which indicates a very decent valuation of CVE-PR-E.
CVE-PR-E's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, CVE-PR-E is valued a bit cheaper.
Industry RankSector Rank
PE 15.38
Fwd PE 11.68
CVE-PR-E.CA Price Earnings VS Forward Price EarningsCVE-PR-E.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

77.38% of the companies in the same industry are more expensive than CVE-PR-E, based on the Enterprise Value to EBITDA ratio.
69.68% of the companies in the same industry are more expensive than CVE-PR-E, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.91
EV/EBITDA 5.36
CVE-PR-E.CA Per share dataCVE-PR-E.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

CVE-PR-E's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CVE-PR-E has a very decent profitability rating, which may justify a higher PE ratio.
CVE-PR-E's earnings are expected to grow with 26.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)0.45
EPS Next 2Y26.34%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.97%, CVE-PR-E has a reasonable but not impressive dividend return.
CVE-PR-E's Dividend Yield is a higher than the industry average which is at 6.94.
Compared to an average S&P500 Dividend Yield of 2.33, CVE-PR-E pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.97%

5.2 History

The dividend of CVE-PR-E is nicely growing with an annual growth rate of 31.72%!
CVE-PR-E has paid a dividend for at least 10 years, which is a reliable track record.
As CVE-PR-E did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)31.72%
Div Incr Years0
Div Non Decr Years9
CVE-PR-E.CA Yearly Dividends per shareCVE-PR-E.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

49.94% of the earnings are spent on dividend by CVE-PR-E. This is a bit on the high side, but may be sustainable.
CVE-PR-E's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP49.94%
EPS Next 2Y26.34%
EPS Next 3YN/A
CVE-PR-E.CA Yearly Income VS Free CF VS DividendCVE-PR-E.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B
CVE-PR-E.CA Dividend Payout.CVE-PR-E.CA Dividend Payout, showing the Payout Ratio.CVE-PR-E.CA Dividend Payout.PayoutRetained Earnings

More info and screens

CENOVUS ENERGY INC - CVECN 4.591 PERP

TSX:CVE-PR-E (3/7/2025, 7:00:00 PM)

25.23

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)04-29 2025-04-29/bmo
Inst Owners50.86%
Inst Owner ChangeN/A
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap46.02B
Analysts81.82
Price Target37.4 (48.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.97%
Yearly Dividend0.84
Dividend Growth(5Y)31.72%
DP49.94%
Div Incr Years0
Div Non Decr Years9
Ex-Date03-14 2025-03-14 (0.28694)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-39.05%
Min EPS beat(2)-72.57%
Max EPS beat(2)-5.52%
EPS beat(4)1
Avg EPS beat(4)-21.32%
Min EPS beat(4)-72.57%
Max EPS beat(4)14.37%
EPS beat(8)4
Avg EPS beat(8)-9.42%
EPS beat(12)6
Avg EPS beat(12)-10.62%
EPS beat(16)7
Avg EPS beat(16)-22.38%
Revenue beat(2)1
Avg Revenue beat(2)-6.41%
Min Revenue beat(2)-16.62%
Max Revenue beat(2)3.8%
Revenue beat(4)2
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-16.62%
Max Revenue beat(4)9.24%
Revenue beat(8)4
Avg Revenue beat(8)-1.23%
Revenue beat(12)8
Avg Revenue beat(12)6.25%
Revenue beat(16)12
Avg Revenue beat(16)7.51%
PT rev (1m)3.12%
PT rev (3m)2.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.59%
EPS NY rev (1m)3.48%
EPS NY rev (3m)9.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.82%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE 15.38
Fwd PE 11.68
P/S 0.85
P/FCF 10.91
P/OCF 4.98
P/B 1.55
P/tB 1.72
EV/EBITDA 5.36
EPS(TTM)1.64
EY6.5%
EPS(NY)2.16
Fwd EY8.56%
FCF(TTM)2.31
FCFY9.17%
OCF(TTM)5.06
OCFY20.07%
SpS29.76
BVpS16.31
TBVpS14.71
PEG (NY)0.49
PEG (5Y)0.45
Profitability
Industry RankSector Rank
ROA 5.49%
ROE 10.44%
ROCE 10.34%
ROIC 8.18%
ROICexc 8.73%
ROICexgc 9.31%
OM 9.37%
PM (TTM) 5.72%
GM 32.49%
FCFM 7.77%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
ROICexc(3y)12.89%
ROICexc(5y)N/A
ROICexgc(3y)13.8%
ROICexgc(5y)N/A
ROCE(3y)15.07%
ROCE(5y)N/A
ROICexcg growth 3Y-0.51%
ROICexcg growth 5Y16.37%
ROICexc growth 3Y0.11%
ROICexc growth 5Y16.58%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.52
Debt/EBITDA 1.01
Cap/Depr 102.96%
Cap/Sales 9.24%
Interest Coverage 250
Cash Conversion 92.75%
Profit Quality 135.87%
Current Ratio 1.42
Quick Ratio 0.81
Altman-Z 2.61
F-Score5
WACC7.2%
ROIC/WACC1.14
Cap/Depr(3y)91.58%
Cap/Depr(5y)68.62%
Cap/Sales(3y)7.67%
Cap/Sales(5y)7.01%
Profit Quality(3y)110.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.59%
EPS 3Y87.24%
EPS 5Y33.99%
EPS Q2Q%-81.79%
EPS Next Y31.65%
EPS Next 2Y26.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.97%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-9.19%
Revenue Next Year-8.97%
Revenue Next 2Y-4.95%
Revenue Next 3Y-3.42%
Revenue Next 5YN/A
EBIT growth 1Y-9.6%
EBIT growth 3Y1.79%
EBIT growth 5Y24.73%
EBIT Next Year121.01%
EBIT Next 3Y31.64%
EBIT Next 5Y23.65%
FCF growth 1Y36.57%
FCF growth 3Y7.94%
FCF growth 5Y14.96%
OCF growth 1Y25%
OCF growth 3Y15.98%
OCF growth 5Y22.96%